Summary Transforming growth factor-a (TGF-oa)-mediated autocrine regulation in human non-small-cell lung cancer (NSCLC) cells NCI-H226 and its brain metastatic variant H226Br were compared. An enhanced TGFcx-induced dose-dependent mitogenic responsiveness in H226Br cells was observed. Neutralising antibody that binds TGF-a inhibits H226Br cell growth more effectively than NCI-H226 cell growth. Binding assay with 12511 labelled epidermal growth factor (EGF) revealed that H226Br has two types of EGF receptors (EGFRs), whereas the parental cell line, NCI-H226, has only one. H226Br cells contain twice as many EGFRs as H226 cells, as proved by Scatchard analysis and immune kinase assay. Northern analysis indicated that there is more EGFR transcript in H226Br than in NCI-H226, indicating a transcriptional EGFR gene elevation during metastasis progression. The level of accumulated immunoactive TGF-a is lower in the conditioned medium of H226Br than in that of NCI-H226, demonstrating down-regulation of TGF-cc transcript. The accumulated data suggest an elevated and sensitive autocrine modulation by TGF-a and EGFR in immortalising the brain metastatic variant cells that were derived from a human NSCLC squamous cell line.
Regulation of cell growth factors and the production of receptors that lead to different autocrine stimulation is a common phenomenon in many tumour cell types (Browder et al., 1989) . Epidermal growth factor receptor (EGFR) is expressed in human lung cancer cell lines (Haeder et al., 1988) . Human EGFR is a single-chain transmembrane glycoprotein with intrinsic tyrosine-protein kinase activity (Carpenter, 1987; Carpenter et al., 1979; Hunter and Cooper, 1979) that is stimulated by EGF or EGF-like factors (Ullrich and Schlessinger, 1990; MacDonald et al., 1990) . EGFR is responsible for the mediation of proliferative responses in many tumour cells and tissues (Fitzpatrick et al., 1984; Xu et al., 1984) . Elevated expression or activity of EGFR has been reported in normal human keratinocytes (Coffey et al., 1987) and neoplasms of the human prostate (Gelman, 1991) , bladder (Smith et al., 1989) , breast (Ro et al., 1988) and head and neck (Ishitoya et al., 1989) as well as in brain (Liberman 1984) , kidney (Petrides et al., 1990) and colon carcinoma cells (Untawale et al., 1993) , transformed mammary epithelium (Valverius et al., 1989) , and mesothelium (Bermudez et al., 1990) .
Transforming growth factor-cc (TGF-a) is a 50 amino acid polypeptide that belongs to the epidermal growth factor family (Massaugue and Pandiella, 1993) and binds to EGFR with a high affinity. It activates cell growth by tyrosine phosphorylation of EGFR. Thus, the increased EGFR activity in tumorigenesis is attributed to autocrine stimulation by TGF-a (Di Marco et al., 1989) , which is produced by a variety of retrovirus-, chemical-and oncogene-transformed human and rodent cell lines (Coffey et al., 1992; Aaronson, 1993) . TGF-ac competes with EGF for binding to EGFR because of their structural similarity (Todaro and DeLarco, 1976; Todaro et al., 1980) . According to the autocrine hypothesis, the TGF-a produced by transformed cells acts on the cell-surface EGFR to promote unstained cell proliferation (Salomon et al., 1990; Sporn and Roberts, 1985) . Increases in EGFR levels have also been caused by gene amplification (King et al., 1985) , enhanced transcription (Downward et al., 1984) and a decreased metabolic turnover rate (Gamou and Shimiyu, 1987) . Expression of EGFR and TGF-a in human non-small-cell lung cancer (NSCLC) has been reported (Rabiasz et al., 1992; Rusch et al., 1993) , but very few detailed studies on TGF-cx activity in NSCLC cells have been reported.
In this study, the molecular mechanisms for TGF-aregulated autocrine activity of NSCLC cells and their metastatic variants were investigated. Squamous cell carcinoma cells are known for their brain metastasis potential (Schackert et al., 1989; Fidler and Schackert, 1991) . The cell line used in this report, H226Br, was derived by intracarotid injection of human NSCLC cells NCI-H226 into athymic BALB/c mice and selected from the developed brain tumour (Hwang et al., 1995) . An enhanced TGF-amediated mitogenic response in H226Br cells was observed. The role of EGFR and the TGF-ac ligand of both cultured cell lines was compared. We found that EGFR expression of H226Br cells is elevated to varying extents, whereas ligand TGF-a expression is decreased compared with the parental cells NCI-H226. The cell growth of H226Br is inhibited in a dose-dependent manner by TGF-cx-specific antibody, indicating the acquisition of effective TGF-cx-mediated autocrine regulation during brain metastasis progression of human NSCLC cells.
Materials and methods

Cell lines
Human lung squamous cell carcinoma cell lines NCI-H226, NCI-H460 and NCI-H322 were obtained from Dr A Gazdar (Southwestern Medical Centre, Dallas, TX, USA). The cells were grown in RPMI-1640 (Gibco-BRL, Grand Island, NY, USA) medium supplemented with L-glutamine, sodium pyruvate and 5% heat-inactivated fetal calf serum (Intergen, Purchase, NY, USA) in a humidified atmosphere of 5% carbon dioxide. Cell line H226Br was developed by Dr IJ Fidler and was cultured in RPMI-1640 supplemented with 5% heat-inactivated fetal calf serum. The cells were examined and found to be free of mycoplasma contamination.
'25I-labelled EGF binding assay Receptor-grade EGF (Collaborative Research, Boston, MA, USA) was labelled with carrier-free Na'25I (Amersham) using the chloramine-T method (Carpenter and Cohen, 1976) . Cells (5 x 105 per well) were cultured in six-well plates and allowed to attach overnight. The medium was aspirated and replaced with serum-free medium after 3 h incubation. After determination of cell numbers per well, the cells were washed twice with ice-cold phosphate-buffered saline (PBS) supplemented with 0.2% bovine serum albumin (BSA). Various concentrations of 1251-labelled EGF were added to each well. After 2 h incubation at 4°C, the cells were washed in ice-cold PBS three times, and the bound radioactivity was determined after the cells were lysed in a 50 mM sodium hydroxide and 10% sodium dodecyl sulphate (SDS) mixture. The non-specific binding was determined and contained a 100-fold molar excess of native EGF. Calculation of binding sites and the dissociation constant, Kd, were determined by Scatchard analysis (Scatchard, 1949) . The human epidermoid cancer cell line A431 was used as a positive control.
Cell growth proliferation assay Cells were first cultured in 96-well microtitre plates in RPMI-1640 medium supplemented with 5% fetal calf serum overnight. The medium was changed to 200 ,ul of serumfree RPMI-1640 containing insulin (5 pl ml-1), transferrin (10 pg ml-') and sodium selenite (30 pg ml-1) (Avis et al., 1995; Brower et al., 1986) overnight. After 24 h incubation at 37°C with various concentrations of TGF-ax in quadruplicate, the assay was added 20 pl of 3-(4,5-dimethyl-thiazol-2-yl)-2,5-diphenyl-tetrazolium bromide (MTT) (5 mg ml-1; Sigma, St Louis, MO, USA) dissolved in phosphate-buffered saline (PBS) for 4 h. Acid isopropanol (100 pl of 0.04 N hydrochloric acid in isopropanol) was added and mixed thoroughly to dissolve the formazam crystals. The plate was read on a microplate reader, using a 570 nm wavelength while a 630 nm reading was set as the reference (Mosman, 1988) . Readings from cell cultures that were not treated with growth factors were used as controls. Statistical significance were determined using the two-tailed Student's t-test.
Neutralisation assay Cells were seeded into 96-well microtitre plates at a density of 1 x 104 cells per well in 200 pl of growth medium and cultured for 24 h. The cells were rinsed with PBS and the medium changed to 200 pl of serum-free RPMI-1640 medium supplemented with insulin (5 pl ml-'), transferrin (10 pg ml-') and sodium selenite (30 pg ml-'). After a further 24 h incubation at 37°C with either various concentrations of TGF-a monoclonal antibody (Oncogene Science) or non-specific antibody MOPC-21 (Organon Teknika-Cappel, Durham, NC, USA) in quadruplicate, 20 pl of MTT (5 mg ml-') was added, and the reading was taken, as previously described, using a growth proliferation assay.
Immune complex kinase assay for EGFR Kinase assay was performed as previously described with modification (Maxwell et al., 1989) . Cells from 75% confluent flasks were lysed and Dounce homogenised in RIPA lysis buffer [1% Triton X-100, 150 mm sodium chloride, 5 mM EDTA, 1% aprotonin, 5 mM phenylmethylsulphonyl fluoride (PMSF), 10 pg ml-' leupeptin and 20 mM sodium phosphate, chloride, 20 mM Hepes (pH 7.0) and 10 ,UM sodium orthophosphate was added. Phosphorylated proteins were resolved by sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE, 7.5% resolving gels). The gels were washed in 1 N sodium hydroxide at 80°C for 1 h and dried. The dried gels were exposed to Kodak X-Omat film before development.
Biosynthetic labelling and phosphorylation of EGFR in intact cells Cells were cultured at I x 106 cells per 60 mm dish 12 -16 h before labelling. The growth medium was removed, and cells were incubated for 4 h in 1 ml of methionine-free RPMI-1 640 medium containing 10% dialysed fetal calf serum and 80 ,Ci of [35S]methionine (1100 Ci mmol-1; ICN Biomedicals, Costa Mesa, CA, USA). To study phosphorylation in intact cells, the cells were stimulated with 200 ng ml-' EGF for 20 min at 37C. The cells were washed with PBS and extracted with a mixture of 50 mm sodium N-2-hydroxyethylpiperazine-N'-2-ethanesulphonate (pH 7.5), 150 mm sodium chloride, 1 mM ethyleneglycol -bis -(,B-aminoethylether)-N,N,N',N'-tetraacetic acid, 1.5 mM magnesium chloride, 10% glycerol, 1% Triton-X, 4 ,ug ml-' PMSF, 10 ,ug ml-' leupeptin, 10 jg ml-' aprotinin, 100 mM sodium chloride, 10 mM sodium pyrophosphate, 30 mM p-nitrophenyl phosphate and 200 uM sodium orthovanadate. EGFR-specific R, antibody (5 ,l), or antiphosphotyrosine antibody-agarose conjugate (Oncogene Science) (25 ,l), or non-specific antibody MOPC-21 (5 ul) was added to cell lysate, followed by 1.5 h incubation. Fifty microlitres of Staphyloccous aureus was added for 1.5 h at ice-cold temperature. After washing, cell pellets were extracted with SDS-PAGE sample buffer, heated to 100°C for 3 min and applied to vertical slab gels. For fluorography, gels were treated with Enlighting (New England NuclearDupont) before drying. Dried gels were exposed to Kodak XOmat film at -70°C before development.
Northern blot analysis of EGFR gene expression Total RNA from more than 60% confluent cell lines was extracted by guanidinium isocyanate according to published procedures (Chomczynski and Sacchi, 1987) . Poly(A+)RNA was purified by oligo(dT)cellulose-affinity chromatography (Collaborative Research, Bedford, MA, USA) following the protocols. Twenty micrograms of poly(A+) RNA was separated on a 1.2% formaldehyde-denatured agarose gel in 20 mM 3-(N-morpholino)-propanesulphonic acid buffer (pH 7.0) and blotted onto GeneScreen membranes (New England Nuclear, Boston, MA, USA). For hybridisation, the cDNA probe 64-1, containing an 1.8 kb EcoRI fragment of the extracellular region of EGFR was used (Hung et al., 1986 (Valverius et al., 1989) were separated in ethidium bromide-stained 0.8% agarose gel. The gel was transferred to nylon paper and the blot hybridised with digoxigenin-labelled 182 bp probe for TGF-a. The blot was washed and detected with antidigoxigenin -alkaline phosphatase conjugate and visualised with Lumigen PPD chemiluminescent detection reagents (BMB, Mannheim, Germany) and exposed to radiographic film. A 420 bp fragment for ,B-actin (sense primer, 5'-GACTTCGAGCAGGAGATGGCCA-C-3'; and antisense primer, 5'-CTCCTGCTTGCTGATCCACATC-3') (Barral- Netto et al., 1992) was amplified and detected with the 1.8 kb BamHI fragment of the human JJ-actin cDNA clone pHF1.
Determination of secreted immunoactive TGF-oa in conditioned medium Cell-secreted TGF-a in the conditioned medium was measured by RIA according to the published procedure (Walker et al., 1995) . The cells were cultured in serum-free medium for 24 h, and the collected medium centrifuged to remove the non-adherent cells, followed by addition of 1 mM PMSF to inhibit protease activity, and concentrated by Centricon-3 concentrator (Amicon, Beverly, MA, USA). The immunoactive TGF-ax was assayed using anti-human TGF-a polyclonal antibody (Peninsula Laboratories, Belmont, CA, USA). The tracer '25I-labelled human TGF-a was labelled with Iodobeads (Pierce, St Louis, MO, USA; 120 1Ci ig-' labelled TGF-ax). Dose (Figure 1 ). The maximum cellbound radioactivity in H226Br is more than that of the parental cells (Figure 1, inset) .
Enhanced TGF-cx sensitivity in H226Br cells The presence of EGFR in cell suggests that TGF-a may act as autocrine regulator for both cell lines. To determine the effect of TGF-a on the growth of NCI-H226, NCI-H322, NCI-H460 and H226Br, 1 x 104 cells were incubated in serum-free medium before addition of growth factors. After stimulation with 10 ng ml-' TGF-a for 24 h, the growth of NCI-H226, NCI-H322 and NCI-H460 was increased by 24%, 26% and 12% respectively, whereas same numbers of H226Br cells exhibited enhanced dose response with 46% and 58% increase in cell growth in 10 and 100 ng ml-' TGFa respectively (Figure 2a) . As the concentration of exogenous TGF-a was increased to 200 ng ml-, the response of H226Br (Figure 2b ). In addition, TGF-x-specific antibody inhibits H226Br growth more effectively. The cells were cultured in different concentrations of TGF-a-specific antibody. Both cell lines showed a dose-dependent inhibitory effect (H226Br was inhibited more than 50% at the highest titre) with inhibition being reversed in the presence of 20 ng ml-' TGF-a ( Figure  3a) . The results indicate the importance of TGF-a in the external autocrine loop for H226Br. The growth inhibition induced by the TGF-a-specific antibody of the parental cells, NCI-H226 (Figure 3b) , is less distinct than that induced by H226Br. The control cell, NCI-H460, with 1.4 x 104 EGF binding sites per cell (unpublished data), were not affected by the TGF-a-specific antibody at all concentrations tested.
Enhanced EGFR kinase activity in H226Br cells
The autophosphorylation activity of the EGFRs for both cell lines was determined by immunoprecipitation of equal amounts of cell lysates with extracellular domain-specific EGFR monoclonal antibody R, followed by incubation with [y-32P]ATP. EGFR autophosphorylation was shown to be more active in H226Br, corresponding to enhanced ligandbinding capacity for EGFR in H226Br (Figure 4) .
To determine further the function of EGFRs, phosphorylation was conducted with 35S-labelled EGFRs on intact cells. After solubilisation with protease inhibitors, cell lysates were immunoprecipitated with either phosphotyrosine antibody agarose conjugate or EGFR antibody and analysed by SDS-PAGE. The basal phosphorylation level of EGFR was not detected by phosphotyrosine-mediated immunoprecipitation for both cell lines. After sti-mulation with 200 ng ml-' EGF for 20 min, the phosphorylation signal and EGFR could be detected by the electrophoretic mobility shift of EGFR bands (Figure 5 , 1990) . Northern analysis indicated that H226Br cells express more EGFR transcript than NCI-H226 as indicated by the densitometric difference of 10 kb EGFR bands ( Figure 6 ). The result demonstrated that the increased EGFR level of H226Br is the result of enhanced transcriptional activity of the EGFR gene during metastasis.
Expression and regulation of TGF-oa in NCI-H226 and H226Br cells Both cell lines were examined for the immunoactive TGF-a level in the spent media using radioimmunoassay. The media Figure 3 Cell growth affected by TGF-a-specific antibody. Cells
(1 x 104 per well) cultured in 96-well plates containing serum-free RPMI-1640 were incubated with 0.5, 2.5 or 5ygml-' TGF-aspecific antibody (Oncogene Science, Uniondale, NY, USA) with or without human recombinant TGF-a (20ngml-1). After 24h incubation at 37°C, the cells were stained with MTT and read at 590nm as in Figure 2 . Cell cultures that were not treated with TGF-a-specific antibody were counted as 100% controls. 
reported the isolation of a brain metastatic variant cell line H226Br from human NSCLC cells NCI-H226. H226Br was shown to have a different tumorigenic phenotype from the parental cells, (Hwang et al., 1995) . Lung cancer cells studied in this work do not express EGF; instead TGF-ox was found to be expressed as a natural ligand for EGFR (Roth, 1992 Furthermore, the growth of H226Br is inhibited more effectively by TGF-a-specific antibody, indicating that the expressed TGF-ac in H226Br acts as an external autocrine loop regulator in cell growth. The low TGF-a expression in H226Br cells reflects the efficiency of the secreted growth factor as a cell-to-cell communication signal, thereby activating overexpressed EGFR and serving as an autocrine stimulator more effectively than that in the parental cell line NCI-H226. In the control cells, NCI-H322, which have similar numbers of EGF binding sites (4.0 x 104 per cell for NCI-H322 vs 4.5 x 104 per cell for NCI-H226) and high TGFa expression (Figure 7) , a similar TGF-ac-mediated mitogenic response was observed (26% increase for for NCI-H226 in the presence of 10 ng TGF-a per ml of media) (Figure 2a ). In addition, TGF-x-specific antibody is not an effective cell growth inhibitor in NCI-H226. The excess TGF-a release attenuates EGFR down-regulation in the parental cells, unlike the brain metastatic variant (Derynck, 1992) . The accumulated EGFRs serve as efficient functional receptors for TGF-a, as occurs in liver-specific metastasis (Fidler, 1995; Radinsky and Fidler, 1992) . Recent studies have shown that TGF-a and EGFR are located in anterior pituitary and hypothalamus (Fan et al., 1995; Lazar and Blum, 1992) . Thus, it is interesting to discover that the growth factor autocrine regulation that takes place in the brain may account for tumorigenesis of squamous cells once the blood brain-barrier is overcome. The growth of H226Br has been shown to be regulated by insulin-like growth factor I, which differs from the parental cells (Hwang et al., 1995) . Taken together, this work characterising growth factor regulation during malignant transformation provides a better understanding of the spectrum of molecular alteration that occurs during metastasis of brain by human NSCLC cells. Further investigation by blocking TGF-a-mediated growth regulation ought to shed light on better containment of metastasis formation
